![](https://endpts.com/wp-content/uploads/2018/05/ASCO-poster-2017-endpts-social.jpg)
The top winners and losers on ASCO abstract night: Loxo, Blueprint, Jounce, Merck KGaA and more
Let the jousting begin.
The big abstract drop ahead of ASCO — the annual Olympics of cancer R&D — provided some early, quick snapshots that helped drive …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.